Bladder cancer trials in Denmark
20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Aarhus N, Copenhagen, Odense
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 3Taking peopleA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- Where
- Aarhus, Copenhagen, Herlev, Odense, Roskilde
- Age
- 18 years and over
- People
- 641 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06319820 - Phase 3Taking peopleTrial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Where
- Aarhus N
- Age
- 18 years and over
- People
- 454 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06510374 · EU 2024-512029-10-00 - Phase 3Taking peopleA Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
- Where
- Aarhus N
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06545955 · EU 2024-512177-27-01 - Phase 2/3Taking peopleDato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Aalborg, Aarhus N, Copenhagen Oe, Herlev, Næstved
- Age
- 18 years and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 · EU 2024-516906-47-00 - Phase 1Taking peopleCalcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial
- Where
- Roskilde
- Age
- 18 years and over
- People
- 20
- Run by
- Juan Luis Vásquez
See details and how to joinNCT07555769 · EU 2026-526388-39-00 - Phase 3Taking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Aalborg, Aarhus, Copenhagen, Næstved
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00 - No phaseTaking peopleFeasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors
- Where
- Herlev
- Age
- 18 years and over
- People
- 25
- Run by
- Optheras AS
See details and how to joinNCT07860398 - Phase 2Taking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Herlev, Odense C
- Age
- 18 years and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - No phaseNot yet taking people in DenmarkREtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors
- Where
- Aarhus, Roskilde
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT07762820 - Phase 4Taking peopleChemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer
- Where
- Aalborg, Aarhus N, Herlev, Herning, Roskilde
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Aarhus University
See details and how to join2022-502221-18-00 · EU 2022-502221-18-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Odense
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseEnrolling by invitationThe Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
- Where
- Aarhus N, Gødstrup, Horsens, Randers, Viborg
- Age
- 18 years and over
- People
- 2,000
- Run by
- Aarhus University Hospital
See details and how to joinNCT05195515 - No phaseTaking peopleComprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy
- Where
- Odense
- Age
- 65 years and over
- People
- 140
- Run by
- Aarhus University Hospital
See details and how to joinNCT05679557 - No phaseTaking peopleSupporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
- Where
- Aarhus
- Age
- 18 years and over
- People
- 30
- Run by
- University of Aarhus
See details and how to joinNCT07339761 - No phaseTaking peopleThe Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
- Where
- Aarhus N, Herlev, København Ø, Roskilde
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Zealand University Hospital
See details and how to joinNCT07077447 - Phase 4Taking peopleChemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
- Where
- Aalborg, Aarhus N, Herlev, Roskilde
- Age
- 18 years and over
- People
- 272 worldwide
- Run by
- Jakob Kristian Jakobsen
See details and how to joinNCT06781879 - No phaseEnrolling by invitationStudy of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02
- Where
- Aarhus
- Age
- 18 years and over
- People
- 64
- Run by
- Cystotech
See details and how to joinNCT06780358 - Phase 4Taking peopleClinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
- Where
- Aalborg, Aarhus, Copenhagen, Herlev, Odense
- Age
- 18 years and over
- People
- 248
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT06709196 · EU 2024-514312-27-00 - No phaseTaking peopleOutpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
- Where
- Aarhus
- Age
- 18 years and over
- People
- 145
- Run by
- Jørgen Bjerggaard Jensen
See details and how to joinNCT05337397